Stay updated on Abemaciclib Pembrolizumab in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Abemaciclib Pembrolizumab in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abemaciclib Pembrolizumab in Head and Neck Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T05:43:46.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:41:46.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The webpage has undergone significant content changes, including the removal of detailed information about a clinical trial for abemaciclib in combination with pembrolizumab for head and neck cancer, while adding a new version revision and a mention of the study's location.
    Difference
    38%
    Check dated 2025-04-16T01:13:51.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T19:42:03.000Z thumbnail image
  7. Check
    95 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T13:35:25.000Z thumbnail image
  8. Check
    109 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T08:54:15.000Z thumbnail image

Stay in the know with updates to Abemaciclib Pembrolizumab in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abemaciclib Pembrolizumab in Head and Neck Cancer Clinical Trial page.